Literature DB >> 7119136

A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).

S D Brinkman, N Pomara, P J Goodnick, N Barnett, E F Domino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7119136

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

1.  Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.

Authors:  G L Corona; M L Cucchi; P Frattini; G Santagostino; S Schinelli; A Romani; A Pola; F Zerbi; F Savoldi
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 2.  Critical review of clinical trials in senile dementia--II.

Authors:  J M Orgogozo; R Spiegel
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

3.  Alzheimer's disease. Is it worth treating?

Authors:  L E Hollister
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

4.  High-affinity [3H]THA (tetrahydroaminoacridine) binding sites in rat brain.

Authors:  E E Mena; M C Desai
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

5.  Scopolamine challenges in Alzheimer's disease.

Authors:  T Sunderland; P Tariot; D L Murphy; H Weingartner; E A Mueller; R M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice.

Authors:  E Abe; S Murai; H Saito; Y Masuda; Y Takasu; T Shiotani; H Tachizawa; T Itoh
Journal:  J Neural Transm Gen Sect       Date:  1994
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.